Dengue fever: A regular epidemic?

Journal of the Pakistan Medical Association

Volumn 58, Issue 1, 2008, Pages 1-2

  Ahsan, Tasnim ^a  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFUSION FLUID;

AEDES AEGYPTI; ANTIBODY PRODUCTION; CLINICAL FEATURE; CROSS REACTION; DENGUE; DENGUE VIRUS; DISEASE CARRIER; DISEASE CLASSIFICATION; EDITORIAL; ENDEMIC DISEASE; EPIDEMIC; FATALITY; HUMAN; INCUBATION TIME; INFECTION PREVENTION; MORBIDITY; MOSQUITO; PAKISTAN; THROMBOCYTE COUNT; URBANIZATION; VECTOR CONTROL; WORLD HEALTH ORGANIZATION; HEALTH;

DENGUE; DISEASE OUTBREAKS; HUMANS; PAKISTAN; WORLD HEALTH;

EID: 43049118310     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Peterson LR, Gulber DJ. Flaviviruses. In : Warrel DA, Cox TM, Firth JD, eds. Oxford Textbook of Medicine: New York: Oxford University Press, 2005: pp 382-5.
2. Guha-Sapir D, Schimmer B. Dengue Fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2005; 2:1.
3. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002;2:33-42.
4. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995;1:55-57.
5. Gubler DJ. The global emergencies/resurgence of arboviral diseases as public health problems. Arch Med Res 2002; 33:330-42.
6. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ 2002; 324:1563-6.
7. Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 1977;146:201-17.
8. Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140:527-33.
9. Halstead SB. Immune enhancement of viral infection. Prog Allergy 1982;31:301-64.
10. Setiati TE, Mairuhu AT, Koraka P, Supriatna M, Mac Gillavry MR, Brandjes DP et al . Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system . BMC Infect Dis 2007; 7: 22.
11. World Health Organization: Dengue Haemorrhagic Fever: diagnosis, treatment, prevention and control 2nd ed. Geneva: WHO 1997.
12. George R. Problems in diagnosis and classification of dengue virus infection. Malays J Pathol 1993; 15:25-7.
13. Murgue B, Deparis X, Chungue E, Cassar O, Roche C. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory -confirmed cases . Trop Med Int Health 1999; 4:765-73.
14. Phuong CX, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful ? Am J trop Med Hyg 2004; 70: 172-9.
15. Rigau-Perez JG, Bonilla GL. An evaluation of modified case definitions for the detection of dengue hemorrhagic fever. Puerto Rico Association of Epidemiologists. P R Health Sci J 1999; 18:347-52.
16. Vaughn DW, Green S. Dengue and dengue hemorrhagic fever. In: Strickland GT, ed. Hunter's tropical medicine and emerging infectious disease: Philadelphia: Saunders, 2000:240-1.
17. Wilder-Smith A, Earnest A, Paton NI . Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever. Clin Infect Dis 2004; 39:1818-23.
18. Watt G, Jongsakul K, Chouriyagune C, Paris R. Differentiating dengue virus infection from scrub typhus in Thai adults with fever. Am J Trop Med Hyg 2003; 68:536-8.
19. Wilder-Smith A, Schwartz E. Dengue in Travelers. N Engl J Med 2005 ; 353:924-32.
20. Barrett AD. Current status of Flavivirus vaccines. Ann N Y Acad Sci 2001; 951:262-71.